Dianthus Therapeutics | MGTA - Trade Creditors


Dianthus Therapeutics reported $5.27M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Avita Medical AUD 8.96M 1.69M Dec/2025
Celltrion KRW 88.58B 9.9B Mar/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Kangmei Pharma CNY 2.46B 153.5M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Moderna USD 161M 156M Mar/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Ovoca Bio EUR 186K 23K Jun/2025
Pharma Mar EUR 43.83M 10.51M Mar/2026
Qiagen NV USD 72.66M 2.11M Dec/2025
Revvity USD 169.68M 15.78M Mar/2026
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.2B 93.9M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026
Zealand Pharma A/S 346.6M 102.71M Dec/2025
Zz Pientze Pharmaceu CNY 457.05M 59.09M Mar/2026